栄研化学JP:4549損益計算書

時価総額
¥949.3億
PER
21.5倍
検査薬の製造販売を主な事業とし、中国では栄研生物科技が受託生産と仕入製造販売を手がける企業。
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
売上高27,70228,64530,02731,01432,16333,27434,99135,76136,58538,66742,99643,27140,05240,539
売上原価---18,14718,76119,11020,29020,06920,35520,13722,43122,76523,32824,027
売上総利益---12,86713,40214,16314,70115,69216,22918,52920,56420,50616,72316,512
売上総利益率(%)---
営業利益---2,8263,5363,9763,4784,6114,6226,6128,3877,4573,3772,999
営業費用---10,0419,86610,18611,22011,08011,60811,91412,18413,04913,34513,512
経常(税引前)利益2,5432,8123,0953,0133,5704,1123,5494,6814,7236,8088,5087,5683,5683,198
法人税等合計---9049609268651,2011,1851,8252,2631,856869763
純利益1,4222,4011,9592,1002,4292,9182,6083,4473,5385,0446,2185,7362,6342,228
一株あたり利益80.38134.98109.13115.13132.85159.3971.2193.6395.95136.65168.28155.1771.6964.82
希薄化後一株あたり利益79.66133.56107.84113.85131.43157.670.3492.8495.21135.6167.01153.8671.164.27
配当性向(%)--------
一株あたり配当金3035353540505030304151515153